by Biocross | Feb 4, 2013 | News
Biocross is a biotechnology company that was created in the National Center for Biotechnology in Madrid, and recently moved to the bioincubator in Boecillo Technology Park (Valladolid). The company has suceeded in identifying key markers in blood samples that serve as...
by Biocross | Oct 17, 2012 | News
Biocross is a biotechnology company that was created in the National Center for Biotechnology in Madrid, and recently moved to the bioincubator in Boecillo Technology Park (Valladolid). The company has suceeded in identifying key markers in blood samples that serve as...
by Biocross | Mar 21, 2012 | News
Early diagnosis a key tool in the fight against disease. It is thus essential that currently available tools are continually improved. Biocross has defined 3 main objectives that will guide the direction of this project. BioCross: Método multiparamétrico para el...
by Biocross | Sep 21, 2011 | Press release
Biocross announces approval of a clinical study for the identification in blood of markers for the diagnosis of Alzheimer’s disease using a multiparametric test – September 2011 The project, entitled “Identification of markers in blood for multiparametric...
by Biocross | Jul 4, 2011 | News
After nearly six months of inactivity, venture capital firm Ade Sodical, owned by the Junta de Castilla y Leon, has been reactivated with an investment in Biocross. More...
